- CA$46.01m
- CA$46.99m
- 46
- 43
- 65
- 50
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.044 | 0.037 | 0.08 | 2.9 | 2.54 |
Operating Profit | -0.044 | -0.037 | -0.08 | -2.9 | -2.54 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.043 | -0.037 | -0.08 | -2.89 | -2.53 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.032 | 0.028 | -0.06 | -2.89 | -2.53 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.032 | 0.028 | -0.06 | -2.89 | -2.53 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.032 | 0.028 | -0.06 | -2.89 | -2.53 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.01 | 0.009 | -0.015 | -0.121 | -0.046 |